Evidence Based Dietary and Pharmacologic Approaches to Manage Patients with Hyperkalemia and Associated Comorbidities

Nephrology

Oct 17, 2022

- Oct 16, 2023

Evidence Based Dietary and Pharmacologic Approaches to Manage Patients with Hyperkalemia and Associated Comorbidities – Modules 1 & 2

EARNed Credit

1.0

AMA PRA Category 1 Credit^TM

Overview

This CME program will highlight evidence based dietary and pharmacologic approaches to manage patients with hyperkalemia. Starting with module 1, Dr. Biff Palmer will review the science of recurrent hyperkalemia, including relationships between dietary potassium intake, serum potassium, and patient morbidities. Next, in module 2, Dr. Pamela Kushner will evaluate the limitations and impact of plant-based diets and potassium restricted diets on the incidence and severity of hyperkalemia. Following both modules, Dr. George Bakris will lead the faculty in an interactive panel discussion, delving into how to better manage patients with hyperkalemia and associated comorbidities.

Who Should Attend

Nephrologists, Primary Care Physicians, Internal Medicine, Nutritionists, Renal Dieticians and other healthcare providers who treat patients with hyperkalemia

Provided By

Course Faculty

George Bakris, MD

Professor of Medicine Director, AHA Comprehensive Hypertension Center University of Chicago Medicine Chicago, IL

Pamela Kushner, MD

Clinical Professor of Family Medicine University of California Medical Center Orange, CA

Biff Palmer, MD

Professor of Internal Medicine Distinguished Teaching Professor University of Texas Southwestern Medical Center Dallas, TX

Learning Objectives

Review the science of recurrent hyperkalemia, including relationships between dietary potassium intake, serum potassium, and patient morbidities

Understand the limitations and impact of plant-based diets and potassium restricted diets on the incidence and severity of hyperkalemia

Course Agenda

Module 1 – Scientific Review of Recurrent Hyperkalemia: Dietary Potassium Intake, Serum Potassium, and Patient Morbidities

Module 2 – The Limitations and Impact of Plant-based Diets and Potassium Restricted Diets on Preventing Hyperkalemia

Additional Course Information

Disclosures of Relevant Financial Relationships

It is the policy of AcademicCME that all faculty, instructors, and planners disclose relevant financial relationships relating to the topics of this educational activity. Any relevant financial relationships are mitigated via a content review by planning committee members and faculty with no relevant financial relationships.

The faculty reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CE activity:

Faculty	Relationship Identified With:
George Bakris, MD	*Consultant/Advisor:* Alnylam; AstraZeneca; Bayer; DiaMedica Therapeutics; InREGEN; Ionis; Janssen; KBP Biosciences; Novo Nordisk; Quantum Genomics
Pamela Kushner, MD	*Consultant/Advisor:* AstraZeneca; Abbot; Bayer; BI/Lily; Intuity; Janssen; GSK *Speaker’s Bureau:* AstraZeneca; Bayer; BI/Lily; Janssen; GSK
Biff Palmer, MD	Nothing to disclose

Planners and Peer Reviewers

Timothy Hayes, MD, PhD; Kim Cheramie, MSN, RN-BC; Chelsey Benedek and Nicole McMenamin hereby state that they or their spouse/life partner do not have any relevant financial relationships to products or devices with any commercial interests related to the content of this activity of any amount during the past 12 months.

Accreditation Statement

In support of improving patient care, AcademicCME is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Credit Designation Statements

AcademicCME designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit^TM.

Financial Support

This activity has been supported by an independent educational grant from AstraZeneca.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. AcademicCME and AstraZeneca do not recommend the use of any agent outside of the labeled indications.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Method of Participation

In order to claim credit, participants must complete the following:

Read the learning objectives, accreditation information and faculty disclosures at the beginning of this activity.
Complete the Pre-Activity Questions
Read or Review the activity content.
Complete the Post-Activity Test Questions and Evaluation.
Learners who receive a grade of 60% or better on the Post-Activity Test Questions and complete the Evaluation will receive appropriate credit as indicated (CME, CNE, and/or CPE credit).

CME and CNE credit will be issued appropriate certificate of completion.
Others may request a “certificate of completion”.

Learners should claim only the credit commensurate with the extent of their participation in the activity.

CE Inquiries/Special Needs

For all CE inquiries or special needs, please contact admin@academiccme.com.

Nephrology

Oct 17, 2022

- Oct 16, 2023